IP Library › Granted Patent US 10,563,040
Granted Patent B2
US 10,563,040 · App. 15/621,323 · Granted Feb 18, 2020

Low-temperature curable compositions

Inventors: Thauming Kuo (Kingsport, TN); Vasudev R. Bhonde (Johnson City, TN); Phillip Bryan Hall (Jonesborough, TN)
Assignee: Eastman Chemical Company
C08K5/07C07C69/38C08G16/04C08G63/16C08G63/20C08G63/914C08K5/053C08K5/092C09D167/02C08L35/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,563,040
App. No.
15/621,323
Granted
Feb 18, 2020
Kind
B2
Abstract

This invention pertains to a curable composition comprising a first component having beta-ketoacetate and/or malonate functionalities and a second component having two or more aldehyde functionalities. The compositions can be cured at room temperature or low temperatures to yield crosslinked networks that are capable of providing desirable properties for coating and adhesive applications. The reactive functionalities of beta-ketoacetate, malonate, and aldehyde can be either on polymers as the main binders or on small molecules as the crosslinkers. The curable compositions desirably are either solventless or organic solvent based.

Claims (45)

1. A curable composition comprising:

I. a first component having two or more functional groups selected from the group consisting of β-ketoacetate and malonate functional groups;

II. a second component vinyl polymer having two or more aldehyde functional groups; and

III. a basic catalyst.

2. The composition of claim 1 , wherein the ratio of the ketoacetate and/or malonate-functionalities in the first component and the aldehyde functionality in the second component is from about 1.05 to about 1.0.

3. The composition of claim 1 , wherein the first component is a polyester having two or more beta-ketotoacetate groups, or two or more malonate groups or both beta-ketotoacetate groups and malonate groups.

4. The composition of claim 1 , wherein the first component is a polyester having two or more beta-ketotoacetate groups.

5. The composition of claim 1 , wherein the basic catalyst is one or more selected from the group consisting of 1,8-diazabicyclo-[5.4.0]undec-7-ene (DBU), 1,5-diazabicyclo[4.3.0]non-5-ene (DBN), 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD), 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD), 1,1,3,3-tetramethylguanidine (TMG), 1,4-diazabicyclo[2.2.2]octane (DABCO), triethylamine, N,N-dimethylethanolamine, ammonium hydroxide, triphenylphosphine, and tributyl phosphine.

6. The composition of claim 1 , wherein the basic catalyst is in an amount ranging from 0.5 to 5 weight % based on the total weight of (I) and (II).

7. The composition of claim 1 further comprising one or more organic solvents selected from the group comprising xylene, methyl amyl ketone, methyl ethyl ketone, 2-butoxyethanol, ethyl-3-ethoxypropionate, toluene, propanol, butanol, cyclopentanone, cyclohexanone, ethyl acetate, and butyl acetate.

8. A curable composition comprising:

I. a first component adduct having two or more β-ketoacetate functional groups;

II. a vinyl polymer having two or more aldehyde functional groups; and

III. a basic catalyst.

9. The composition of claim 8 , wherein the adduct is selected from the group comprising 2,2,4,4-tetramethylcyclobutane-1,3-diol diacetoacetate, glycerol triacetoacetate, trimethylpropane triacetoacetate, pentaerythritol tetraacetoacetate.

10. A curable composition comprising:

I. a first component acetoacetate functional polyester comprising the residues of

a. a hydroxyl component comprising:

i. a diol in an amount ranging from 70 to 100 mole %, based on the total moles of (i) and (ii); and

ii. a polyol in an amount ranging from 0 to 30 mole %, based on the total moles of (i) and (ii);

b. a carboxyl component comprising a polycarboxylic acid compound, a derivative of polycarboxylic acid compound, or a combination thereof; and

c. an alkyl acetoacetate, a diketene, or a combination thereof in an amount ranging from about 5 to about 50 weight %, based on the total weight of (a), (b), and (c);

II. a second component having two or more aldehyde functional groups; and

III. a basic catalyst;

wherein the second component is selected from the group comprising 1,3-cyclohexanedicarboxaldehyde (1,3-CHDAL), 1,4-cyclohexanedicarboxaldehyde (1,4-CHDAL), mixtures of 1,3- and 1,4-CHDAL, 2,6-norbornanedicarboxaldehyde, 2,5-norbornane-dicarboxaldehyde, cyclododecane-1,4,8-tricarbaldehyde, 3,(4-formylcyclohexyl)propanal, and their isomers.

11. The composition of claim 10 , wherein the second component is selected from 1,3-cyclohexanedicarboxaldehyde (1,3-CHDAL), 1,4-cyclohexane-dicarboxaldehyde (1,4-CHDAL), and mixtures of 1,3- and 1,4-CHDAL.

12. The composition of claim 11 , wherein the equivalent ratio of the acetoacetate (AcAc) functionality in the first component and the aldehyde (CHO) functionality in the second component is from about 1.05 to about 1.0.

13. A curable composition comprising:

I. a polyester comprising the residues of:

a. a hydroxyl component comprising:

i. a diol in an amount ranging from 70 to 100 mole %, based on the total moles of (i) and (ii); and

ii. a polyol in an amount ranging from 0 to 30 mole %, based on the total moles of (i) and (ii); and

b. malonic acid, its ester, or a combination thereof; and

c. optionally a carboxyl component, other than malonic acid or its ester, comprising a polycarboxylic acid compound, a derivative of polycarboxylic acid compound, or a combination thereof;

II. an aldehyde component selected from the group consisting of 1,3-cyclohexanedicarboxaldehyde (1,3-CHDAL), 1,4-cyclohexanedicarboxaldehyde (1,4-CHDAL), mixtures of 1,3- and 1,4-CHDAL, 2,6-norbornanedicarboxaldehyde, 2,5-norbornanedicarboxaldehyde, cyclododecane-1,4,8-tricarbaldehyde, 3,(4-formylcyclohexyl)propanal, and their isomers; and

III. a basic catalyst that is one or more selected from the group consisting of 1,8-diazabicyclo-[5.4.0]undec-7-ene (DBU), 1,5-diazabicyclo[4.3.0]non-5-ene (DBN), 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD), 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD), 1,1,3,3-tetramethylguanidine (TMG), 1,4-diazabicyclo[2.2.2]octane (DABCO), triethylamine, N,N-dimethylethanolamine, ammonium hydroxide, triphenyl phosphine, and tributyl phosphine.

14. A curable composition comprising:

I. an acetoacetate functional polyester comprising the residues of:

a. a hydroxyl component comprising:

i. a diol in an amount ranging from 70 to 100 mole %, based on the total moles of (i) and (ii); and

ii. a polyol in an amount ranging from 0 to 30 mole %, based on the total moles of (i) and (ii);

b. a carboxyl component comprising a polycarboxylic acid compound, a derivative of polycarboxylic acid compound, or a combination thereof; and

c. an alkyl acetoacetate, a diketene, or a combination thereof in an amount ranging from about 5 to about 50 weight %, based on the total weight of (a), (b), and (c);

II. an aldehyde component selected from the group consisting of 1,3-cyclohexanedicarboxaldehyde (1,3-CHDAL), 1,4-cyclohexanedicarboxaldehyde (1,4-CHDAL), mixtures of 1,3- and 1,4-CHDAL, 2,6-norbornanedicarboxaldehyde, 2,5-norbornane-dicarboxaldehyde, cyclododecane-1,4,8-tricarbaldehyde, 3,(4-formylcyclohexyl)propanal, and their isomers; and

III. a basic catalyst that is one or more selected from the group consisting of 1,8-diazabicyclo-[5.4.0]undec-7-ene (DBU), 1,5-diazabicyclo[4.3.0]non-5-ene (DBN), 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD), 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD), 1,1,3,3-tetramethylguanidine (TMG), 1,4-diazabicyclo[2.2.2]octane (DABCO), triethylamine, N,N-dimethylethanolamine, ammonium hydroxide, triphenyl phosphine, and tributyl phosphine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2017
From: KUO, THAUMING; BHONDE, VASUDEV R.; HALL, PHILLIP BRYAN
To: EASTMAN CHEMICAL COMPANY
Reel/Frame 043074/0990 →
Continuity (1)
Related Publication 20180355145A1 · Dec 13, 2018
Cited By (1)
US 12,378,434